Category: Photo

On 16 May, a panel took place at a side event organised by Deep Tech Atelier 2025 "BioPhoT" "Industry's challenges for science" (Industry Challenges for Science).

Industry professionals were invited to share real challenges that require interdisciplinary thinking and new collaborations. Representatives from the life sciences, biomedical, medical technology and pharmaceutical sectors were invited to present technical challenges and a "wish list" for their fields, to receive informal feedback and new ideas from researchers, experts and other professionals, and to make contacts that can lead to collaborations, research projects or co-developed innovations.

Presenters on issues in their fields TBD PharmaTech (Estonia), Lithuania BIO (Lithuania), Molport, PMNet Forum, Cellbox Labs and Roche Latvia representatives.

Photo by Jānis Spurdziņš

15 May with lectureScaling science into impact: the role of research platforms and public-private partnership) by Uppsala University Professor Anders Karlén will take place on the festivals' Deep Tech Stage. Professor Anders Karlén from Uppsala University took to the stage.

His research focuses on the identification of starting materials and the development of potential drugs for antimicrobial drug discovery. Between 2014 and 2021, Prof. Karlén was the head of the lead unit and co-coordinator of the Innovative Medicines Initiative (IMI) project ENABLE. He is currently the coordinator of the national project ENABLE-2, the follow-up to ENABLE. Since 2019, he is leading the six-year IMI-2 project COMBINE, part of the IMI Antimicrobial Resistance (AMR) Accelerator Initiative.

Prof. Karlén outlined the contribution of the ENABLE platform to addressing the needs of the pharmaceutical industry and public health.

This was followed by Panel discussionThe future of innovation: industry collaboration and sustainable science funding at 15.50.).

Experts - Jurģis Miezainis, Parliamentary Secretary, Ministry of Economics of the Republic of Latvia, Vitālijs Skrīvelis, PharmIdea SIA Board Member and Co-Owner, Osvalds Pugovičs, Deputy Director of the Latvian Institute of Organic Synthesis and BioPhoT Platform Manager, Joanna Lipner, Picralida co-founder and Executive Director - moderated by Sandra Kropa, will discuss how long-term financial support fosters scientific discovery and accelerates technology commercialisation.

Photo by publicity and Lauris Viksne.

Deep Tech Atelier 2025 was launched on 14 May at the Riga Technical University (RTU) Science and Innovation Centre with an event organised by the European Institute of Technology (EIT) "Commercialising Research: Deep Tech and Open Labs".

The event aimed to strengthen the link between science and business, while fostering the development of the next generation of deep tech leaders. The BioPhoT platform was presented at the event as an example of successful collaboration between science and industry.

Photo by Gints Ivuškāns

On 21 May, Scott Dax, PhD in Chemistry (USA), presented his biotechnology commercialisation experience at the Organic Synthesis Institute (OSI). He is an expert in the discovery and development of new drugs with more than 25 years of experience in drug development and commercialisation of ideas. Read more.

Photo by Inese Kalniņa